We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRI icon
576
Primerica
PRI
$9.89B
$15M 0.03%
153,795
-8,522
-5% -$948K
DISCK
577
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$15M 0.03%
650,885
+1,103
+0.2% +$30.7K
DGRW icon
578
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$15M 0.03%
390,936
+213,150
+120% +$8.81M
COR icon
579
Cencora
COR
$61.2B
$14.9M 0.03%
200,789
-6,261
-3% -$540K
XEC
580
DELISTED
CIMAREX ENERGY CO
XEC
$14.9M 0.03%
241,453
-16,681
-6% -$1.37M
BMRN icon
581
BioMarin Pharmaceuticals
BMRN
$12.4B
$14.8M 0.03%
174,368
+120
+0.1% +$11.4K
IXN icon
582
iShares Global Tech ETF
IXN
$9.26B
$14.8M 0.03%
618,006
-21,576
-3% -$564K
WSO icon
583
Watsco Inc
WSO
$13.6B
$14.8M 0.03%
106,614
+4,040
+4% +$616K
BIP icon
584
Brookfield Infrastructure Partners
BIP
$18B
$14.8M 0.03%
720,780
-19,524
-3% -$445K
CBSH icon
585
Commerce Bancshares
CBSH
$8.5B
$14.8M 0.03%
369,157
+25,403
+7% +$1.09M
MPT
586
Medical Properties Trust
MPT
$2.81B
$14.8M 0.03%
919,680
-646,136
-41% -$10.2M
HBI
587
DELISTED
Hanesbrands
HBI
$14.8M 0.03%
1,179,533
-111,711
-9% -$1.74M
NDAQ icon
588
Nasdaq
NDAQ
$52.9B
$14.8M 0.03%
543,339
+7,731
+1% +$220K
OHI icon
589
Omega Healthcare
OHI
$14.7B
$14.7M 0.03%
419,132
-120,059
-22% -$4.16M
ICLR icon
590
Icon
ICLR
$12.7B
$14.7M 0.03%
113,623
-9,957
-8% -$1.38M
AME icon
591
Ametek
AME
$58.2B
$14.6M 0.03%
215,493
+185
+0.1% +$13.3K
PH icon
592
Parker-Hannifin
PH
$135B
$14.5M 0.03%
97,531
-22,134
-18% -$3.58M
VTA
593
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$14.5M 0.03%
1,415,119
+1,056,205
+294% +$11.5M
UPGD icon
594
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
$14.4M 0.03%
394,878
-45,907
-10% -$1.96M
TECD
595
DELISTED
Tech Data Corp
TECD
$14.3M 0.03%
175,308
+98,188
+127% +$7.45M
LDOS icon
596
Leidos
LDOS
$17.3B
$14.3M 0.03%
272,026
-6,748
-2% -$419K
AL
597
DELISTED
Air Lease Corp
AL
$14.3M 0.03%
474,254
-7,386
-2% -$282K
ATVI
598
DELISTED
Activision Blizzard
ATVI
$14.2M 0.02%
304,077
-119,064
-28% -$7.13M
AOM icon
599
iShares Core Moderate Allocation ETF
AOM
$1.78B
$14.1M 0.02%
396,346
+378,890
+2,171% +$13.8M
BN icon
600
Brookfield
BN
$108B
$14.1M 0.02%
1,040,705
+181,794
+21% +$2.71M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.